Pimavanserin Capsules 10 mg, Pimavanserin 34 mg Capsule, Pimavanserin 20 mg Capsule
ACP-103-070
Phase 2 small_molecule active
Quick answer
Pimavanserin Capsules 10 mg, Pimavanserin 34 mg Capsule, Pimavanserin 20 mg Capsule for Irritability associated with autistic disorder in children and adolescents with ASD is a Phase 2 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Irritability associated with autistic disorder in children and adolescents with ASD
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active